Patents Assigned to Tela Bio, Inc.
-
Patent number: 11864987Abstract: Stitching patterns overlap to produce a corner-locked stitch pattern. The corner-locked stitch pattern includes one or more thread interlace points, and one or more overlays of threads from overlapping patterns. A network of corner-lock stitch patterns produces a mesh, which may be embroidered into a substrate, such as a medical textile or biotextile. Corner-lock stitch patterns resist puncture-induced and tension-induced deformation of mesh pores between corner-locked stitch patterns, and may be used to modulate compliance and enhance strength properties of a substrate into which they are sewn.Type: GrantFiled: March 31, 2022Date of Patent: January 9, 2024Assignee: TELA Bio, Inc.Inventors: Skott Greenhalgh, John-Paul Romano
-
Publication number: 20230293281Abstract: A hybrid medical device that can aid in reconstructive or augmentative surgery of the breast is disclosed. The device can utilize a suitable biological collagen tissue matrix combined with a synthetic material, for example, that can impart a high initial strength to the repair site while permitting proper healing and revitalization of the implanted device.Type: ApplicationFiled: March 13, 2023Publication date: September 21, 2023Applicant: Tela Bio, IncInventors: E. Skott GREENHALGH, John-Paul ROMANO
-
Patent number: 11628054Abstract: A hybrid medical device that can aid in reconstructive or augmentative surgery of the breast is disclosed. The device can utilize a suitable biological collagen tissue matrix combined with a synthetic material, for example, that can impart a high initial strength to the repair site while permitting proper healing and revitalization of the implanted device.Type: GrantFiled: July 6, 2020Date of Patent: April 18, 2023Assignee: Tela Bio, IncInventors: E. Skott Greenhalgh, John-Paul Romano
-
Patent number: 11590262Abstract: The apparatuses and methods described herein relates generally to the field of active agent (drug) release from surgical grafts useful for soft tissue reconstruction, regeneration, or repair. More particularly, described herein are surgical grafts for soft tissue repair that include active agent that is released over time while advantageously matching the biomechanical properties of tissue during healing and recovery.Type: GrantFiled: March 8, 2019Date of Patent: February 28, 2023Assignee: TELA BIO, INC.Inventor: E. Skott Greenhalgh
-
Patent number: 11464616Abstract: Materials for soft tissue repair, and in particular, material for hernia repair. These materials may be configured as an implant, such as a graft, that may be implanted into a patient in need thereof, such as a patient having a hernia or undergoing a hernia repair surgical procedure. These grafts may include a first layer comprising a substrate (e.g., mesh) and a second layer comprising a sheet of anti-adhesive material. The layers may be attached with a plurality of relatively small attachment sites that are separated by regions in which the two layers are not attached, to provide a highly compliant graft.Type: GrantFiled: February 14, 2020Date of Patent: October 11, 2022Assignee: TELA Bio, Inc.Inventors: Skott Greenhalgh, John-Paul Romano, Travis Speicher
-
Patent number: 11446130Abstract: Described herein are implants (e.g., medical textiles/biotextiles) that include stitched gripping filaments to increase gripping, and methods of forming and using them. In some configurations these apparatuses may be configured as surgical grafts that may be used for soft tissue reconstruction, regeneration, or repair.Type: GrantFiled: March 9, 2020Date of Patent: September 20, 2022Assignee: TELA Bio, Inc.Inventors: E. Skott Greenhalgh, John-Paul Romano, Travis Speicher, Brendan Farrell
-
Patent number: 11369464Abstract: Compliance control stitch patterns sewn or embroidered into biotextile or medical textile substrates impart reinforcing strength, and stretch resistance and control into such substrates. Compliance control stitch patterns may be customizable to particular patients, substrate implantation sites, particular degenerative or diseased conditions, or desired time frames. Substrates having compliance control stitch patterns sewn or embroidered into them may be used in tissue repair or tissue reconstruction applications.Type: GrantFiled: August 28, 2019Date of Patent: June 28, 2022Assignee: TELA Bio, IncInventors: Skott Greenhalgh, John-Paul Romano
-
Patent number: 11344397Abstract: Stitching patterns overlap to produce a corner-locked stitch pattern. The corner-locked stitch pattern includes one or more thread interlace points, and one or more overlays of threads from overlapping patterns. A network of corner-lock stitch patterns produces a mesh, which may be embroidered into a substrate, such as a medical textile or biotextile. Corner-lock stitch patterns resist puncture-induced and tension-induced deformation of mesh pores between corner-locked stitch patterns, and may be used to modulate compliance and enhance strength properties of a substrate into which they are sewn.Type: GrantFiled: February 25, 2019Date of Patent: May 31, 2022Assignee: TELA BIO, INC.Inventors: Skott Greenhalgh, John-Paul Romano
-
Publication number: 20200330211Abstract: A hybrid medical device that can aid in reconstructive or augmentative surgery of the breast is disclosed. The device can utilize a suitable biological collagen tissue matrix combined with a synthetic material, for example, that can impart a high initial strength to the repair site while permitting proper healing and revitalization of the implanted device.Type: ApplicationFiled: July 6, 2020Publication date: October 22, 2020Applicant: Tela Bio, IncInventors: E. Skott GREENHALGH, John-Paul ROMANO
-
Publication number: 20200297476Abstract: Implantable tensile load-bearing grafts having synthetic components stitched through biological components are disclosed. The synthetic components can be biodegradable and/or non-biodegradable and of differing tensile strengths from each other and the biological component. Methods of making the grafts are also disclosed.Type: ApplicationFiled: June 4, 2020Publication date: September 24, 2020Applicant: Tela Bio, IncInventors: E. Skott GREENHALGH, Antony KOBLISH
-
Patent number: 10702364Abstract: A hybrid medical device that can aid in reconstructive or augmentative surgery of the breast is disclosed. The device can utilize a suitable biological collagen tissue matrix combined with a synthetic material, for example, that can impart a high initial strength to the repair site while permitting proper healing and revitalization of the implanted device.Type: GrantFiled: July 19, 2016Date of Patent: July 7, 2020Assignee: Tela Bio, Inc.Inventors: E. Skott Greenhalgh, John-Paul Romano
-
Patent number: 10675141Abstract: Implantable tensile load-bearing grafts having synthetic components stitched through biological components are disclosed. The synthetic components can be biodegradable and/or non-biodegradable and of differing tensile strengths from each other and the biological component. Methods of making the grafts are also disclosed.Type: GrantFiled: September 21, 2016Date of Patent: June 9, 2020Assignee: Tela Bio, IncInventors: E. Skott Greenhalgh, Antony Koblish
-
Patent number: 10561485Abstract: Materials for soft tissue repair, and in particular, material for hernia repair. These materials may be configured as an implant, such as a graft, that may be implanted into a patient in need thereof, such as a patient having a hernia or undergoing a hernia repair surgical procedure. These grafts may include a first layer comprising a substrate (e.g., mesh) and a second layer comprising a sheet of anti-adhesive material. The layers may be attached with a plurality of relatively small attachment sites that are separated by regions in which the two layers are not attached, to provide a highly compliant graft.Type: GrantFiled: November 15, 2017Date of Patent: February 18, 2020Assignee: TELA Bio, Inc.Inventors: Skott Greenhalgh, John-Paul Romano, Travis Speicher
-
Patent number: 10500030Abstract: A hybrid medical device that can aid in reconstructive or augmentative surgery of the breast is disclosed. The device can utilize a suitable biological collagen tissue matrix combined with a synthetic material, for example, that can impart a high initial strength to the repair site while permitting proper healing and revitalization of the implanted device.Type: GrantFiled: July 19, 2016Date of Patent: December 10, 2019Assignee: Tela Bio, IncInventors: E. Skott Greenhalgh, John-Paul Romano
-
Patent number: 10426587Abstract: Compliance control stitch patterns sewn or embroidered into biotextile or medical textile substrates impart reinforcing strength, and stretch resistance and control into such substrates. Compliance control stitch patterns may be customizable to particular patients, substrate implantation sites, particular degenerative or diseased conditions, or desired time frames. Substrates having compliance control stitch patterns sewn or embroidered into them may be used in tissue repair or tissue reconstruction applications.Type: GrantFiled: July 21, 2016Date of Patent: October 1, 2019Assignee: TELA Bio, Inc.Inventors: Skott Greenhalgh, John-Paul Romano
-
Patent number: 10213284Abstract: Stitching patterns overlap to produce a corner-locked stitch pattern. The corner-locked stitch pattern includes one or more thread interlace points, and one or more overlays of threads from overlapping patterns. A network of corner-lock stitch patterns produces a mesh, which may be embroidered into a substrate, such as a medical textile or biotextile. Corner-lock stitch patterns resist puncture-induced and tension-induced deformation of mesh pores between corner-locked stitch patterns, and may be used to modulate compliance and enhance strength properties of a substrate into which they are sewn.Type: GrantFiled: June 29, 2016Date of Patent: February 26, 2019Assignee: TELA Bio, Inc.Inventors: Skott Greenhalgh, John-Paul Romano
-
Patent number: 10130457Abstract: A hybrid medical device that can aid in reconstructive or augmentative surgery of the breast is disclosed. The device can utilize a suitable biological collagen tissue matrix combined with a synthetic material, for example, that can impart a high initial strength to the repair site while permitting proper healing and revitalization of the implanted device.Type: GrantFiled: March 5, 2015Date of Patent: November 20, 2018Assignee: Tela Bio, Inc.Inventors: E. Skott Greenhalgh, John-Paul Romano
-
Patent number: 9925030Abstract: Stitching patterns overlap to produce a corner-locked stitch pattern. The corner-locked stitch pattern includes one or more thread interlace points, and one or more overlays of threads from overlapping patterns. A network of corner-lock stitch patterns produces a mesh, which may be embroidered into a substrate, such as a medical textile or biotextile. Corner-lock stitch patterns resist puncture-induced and tension-induced deformation of mesh pores between corner-locked stitch patterns, and may be used to modulate compliance and enhance strength properties of a substrate into which they are sewn.Type: GrantFiled: October 3, 2016Date of Patent: March 27, 2018Assignee: TELA Bio, Inc.Inventors: Skott Greenhalgh, John-Paul Romano
-
Patent number: 9820843Abstract: Materials for soft tissue repair, and in particular, material for hernia repair. These materials may be configured as an implant, such as a graft, that may be implanted into a patient in need thereof, such as a patient having a hernia or undergoing a hernia repair surgical procedure. These grafts may include a first layer comprising a substrate (e.g., mesh) and a second layer comprising a sheet of anti-adhesive material. The layers may be attached with a plurality of relatively small attachment sites that are separated by regions in which the two layers are not attached, to provide a highly compliant graft.Type: GrantFiled: April 26, 2017Date of Patent: November 21, 2017Assignee: TELA Bio, Inc.Inventors: Skott Greenhalgh, John-Paul Romano, Travis Speicher
-
Patent number: 9775700Abstract: Compliance control stitch patterns sewn or embroidered into biotextile or medical textile substrates impart reinforcing strength, and stretch resistance and control into such substrates. Compliance control stitch patterns may be customizable to particular patients, substrate implantation sites, particular degenerative or diseased conditions, or desired time frames. Substrates having compliance control stitch patterns sewn or embroidered into them may be used in tissue repair or tissue reconstruction applications.Type: GrantFiled: October 3, 2016Date of Patent: October 3, 2017Assignee: TELA Bio, Inc.Inventors: Skott Greenhalgh, John-Paul Romano